Learn the distinguishing features of FDA-approved medications for the treatment of opioid use disorder and consider how these characterstics factor into treatment decisions when providing individualized care tailored to the unique needs of each patient.
Sandra Springer, MD
Christian B. Ramers, MD, MPH
Released: February 6, 2020Expiration: No longer available for credit
This program is divided into several short segments which you can step through using the Video Chapters widget.
Expert HIV faculty analyze new data from CROI 2022, from Clinical Care Options (CCO)
Joseph J. Eron, Jr., MD
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN
Jasjit Gill, BSPharm, PharmD
1.0 Nursing contact hour Pharmacists:
1.0 contact hour (0.1 CEUs) Released: May 10, 2022Expired:
May 9, 2023